Natural killer cell crossmatch: Functional analysis of inhibitory killer immunoglobulin-like receptors and their HLA ligands

Human Immunology

Volumn 68, Issue 6, 2007, Pages 507-513

  Han, Mei ^a   Fallena, Margarita ^a   Guo, Yuhong ^a   Stastny, Peter ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cytotoxicity; KIR; NK cells

Indexed keywords

HLA ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ARTICLE; CELL ACTIVITY; CELL FUNCTION; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; GENETICS; HLA MATCHING; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

BONE MARROW TRANSPLANTATION; CYTOTOXICITY, IMMUNOLOGIC; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; KILLER CELLS, NATURAL; LIGANDS; RECEPTORS, IMMUNOLOGIC;

EID: 34248233184     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2007.02.001     Document Type: Article

References (27)

1. Andoniou C.E., Andrews D.M., and Degli-Esposti M.A. Natural killer cells in viral infection: more than just killers. Immunol Rev 214 (2006) 239
2. Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., and Salazar-Mather T.P. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 17 (1999) 189
3. Roetynck S., Baratin M., Johansson S., Lemmers C., Vivier E., and Ugolini S. Natural killer cells and malaria. Immunol Rev 214 (2006) 251
4. Chisholm S.E., and Reyburn H.T. Recognition of vaccinia virus-infected cells by human natural killer cells depends on natural cytotoxicity receptors. J Virol 80 (2006) 2225
5. Fauci A.S., Mavilio D., and Kottilil S. NK cells in HIV infection: paradigm for protection or targets for ambush. Nat Rev Immunol 5 (2005) 835
6. Lodoen M.B., and Lanier L.L. Viral modulation of NK cell immunity. Nat Rev Microbiol 3 (2005) 59
7. Cerwenka A., and Lanier L.L. Natural killer cells, viruses and cancer. Nat Rev Immunol 1 (2001) 41
8. Diefenbach A., and Raulet D.H. The innate immune response to tumors and its role in the induction of T-cell immunity. Immunol Rev 188 (2002) 9
9. Smyth M.J., Hayakawa Y., Takeda K., and Yagita H. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer 2 (2002) 850
10. Lanier L.L. NK cell recognition. Annu Rev Immunol 23 (2005) 225
11. Vankayalapati R., Garg A., Porgador A., Griffith D.E., Klucar P., Safi H., Girard W.M., Cosman D., Spies T., and Barnes P.F. Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. J Immunol 175 (2005) 4611
12. Tassi I., Klesney-Tait J., and Colonna M. Dissecting natural killer cell activation pathways through analysis of genetic mutations in human and mouse. Immunol Rev 214 (2006) 92
13. Boyington J.C., and Sun P.D. A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors. Mol Immunol 38 (2002) 1007
14. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 5 (2005) 201
15. Pyz E., Marshall A.S., Gordon S., and Brown G.D. C-type lectin-like receptors on myeloid cells. Ann Med 38 (2006) 242
16. Moretta A., Bottino C., Vitale M., Pende D., Biassoni R., Mingari M.C., and Moretta L. Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol 14 (1996) 619
17. Karre K., Ljunggren H.G., Piontek G., and Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. 1986. J Immunol 174 (2005) 6566
18. Long E.O., and Rajagopalan S. HLA class I recognition by killer cell Ig-like receptors. Semin Immunol 12 (2000) 101
19. Long E.O. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol 17 (1999) 875
20. Vilches C., and Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 20 (2002) 217
21. Raulet D.H. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat Immunol 5 (2004) 996
22. Koh C.Y., Ortaldo J.R., Blazar B.R., Bennett M., and Murphy W.J. NK-cell purging of leukemia: superior antitumor effects of NK cells H2 allogeneic to the tumor and augmentation with inhibitory receptor blockade. Blood 102 (2003) 4067
23. Ruggeri L., Capanni M., Urbani E., Perruccio K., Shlomchik W.D., Tosti A., Posati S., Rogaia D., Frassoni F., Aversa F., Martelli M.F., and Velardi A. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295 (2002) 2097
24. Hsu K.C., Liu X.R., Selvakumar A., Mickelson E., O'Reilly R.J., and Dupont B. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol 169 (2002) 5118
25. Pando M.J., Gardiner C.M., Gleimer M., McQueen K.L., and Parham P. The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1. J Immunol 171 (2003) 6640
26. Yawata M., Yawata N., Draghi M., Little A.M., Partheniou F., and Parham P. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med 203 (2006) 633
27. Carr W.H., Pando M.J., and Parham P. KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand. J Immunol 175 (2005) 5222